Inhibition of Glutamine Cellular Uptake Contributes to the Cytotoxic Effect of Xanthohumol in Triple-Negative Breast Cancer Cells

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–49. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Krall AS, Christofk HR. Rethinking glutamine addiction. Nat Cell Biol. 2015;17(12):1515–7. doi:10.1038/ncb3278
   PubMed Web of Science ®Google Scholar
• Teixeira E, Silva C, Martel F. The role of the glutamine transporter asct2 in antineoplastic therapy. Cancer Chemother Pharmacol. 2021;87(4):447–64. doi:10.1007/s00280-020-04218-6
   PubMed Web of Science ®Google Scholar
• Still ER, Yuneva MO. Hopefully devoted to q: Targeting glutamine addiction in cancer. Br J Cancer. 2017;116(11):1375–81. doi:10.1038/bjc.2017.113
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Peiris-Pages M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14(1):11–31. doi:10.1038/nrclinonc.2016.60
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27–47. doi:10.1016/j.cmet.2015.12.006
   PubMed Web of Science ®Google Scholar
• Daye D, Wellen KE. Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis. Semin Cell Dev Biol. 2012;23(4):362–9. doi:10.1016/j.semcdb.2012.02.002
   PubMed Web of Science ®Google Scholar
• Lopes C, Pereira C, Medeiros R. Asct2 and lat1 contribution to the hallmarks of cancer: From a molecular perspective to clinical translation. Cancers (Basel). 2021;13(2):203. doi:10.3390/cancers13020203
   PubMed Web of Science ®Google Scholar
• Zhou P, Liang X, Zhou C, Qin J, Hou C, Zhu Z, Zhang W, Wang S, Zhong D. Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2. J Mater Chem B. 2019;7(35):5363–75. doi:10.1039/c9tb01225g
   PubMed Web of Science ®Google Scholar
• Rasouli H, Farzaei MH, Mansouri K, Mohammadzadeh S, Khodarahmi R. Plant cell cancer: May natural phenolic compounds prevent onset and development of plant cell malignancy? A literature review. Molecules. 2016;21(9):1104–30. doi:10.3390/molecules21091104
   PubMed Web of Science ®Google Scholar
• Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009;2(5):270–8. doi:10.4161/oxim.2.5.9498
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zheng J, Li Y, Xu D-P, Li S, Chen Y-M, Li H-B. Natural polyphenols for prevention and treatment of cancer. Nutrients. 2016;8(8):515–50. doi:10.3390/nu8080515
   PubMed Web of Science ®Google Scholar
• Nichenametla SN, Taruscio TG, Barney DL, Exon JH. A review of the effects and mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr. 2006;46(2):161–83. doi:10.1080/10408390591000541
   PubMed Web of Science ®Google Scholar
• Losada-Echeberria M, Herranz-Lopez M, Micol V, Barrajon CE. Polyphenols as promising drugs against main breast cancer signatures. Antioxidants (Basel). 2017;6(4):88–112. doi:10.3390/antiox6040088
   PubMedGoogle Scholar
• Mocanu M-M, Nagy P, Szöllősi J. Chemoprevention of breast cancer by dietary polyphenols. Molecules. 2015;20(12):22578–620. doi:10.3390/molecules201219864
   PubMed Web of Science ®Google Scholar
• Ci Y, Qiao J, Han M. Molecular mechanisms and metabolomics of natural polyphenols interfering with breast cancer metastasis. Molecules. 2016;21(12):1634–61. doi:10.3390/molecules21121634
   PubMed Web of Science ®Google Scholar
• Moreira L, Araújo I, Costa T, Correia-Branco A, Faria A, Martel F, Keating E. Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism. Exp Cell Res. 2013;319(12):1784–95. doi:10.1016/j.yexcr.2013.05.001
   PubMed Web of Science ®Google Scholar
• Azevedo C, Correia-Branco A, Araújo JR, Guimarães JT, Keating E, Martel F. The chemopreventive effect of the dietary compound kaempferol on the mcf-7 human breast cancer cell line is dependent on inhibition of glucose cellular uptake. Nutr ­Cancer. 2015;67(3):504–13. doi:10.1080/01635581.2015.1002625
   PubMed Web of Science ®Google Scholar
• Araujo JR, Goncalves P, Martel F. Modulation of glucose uptake in a human choriocarcinoma cell line (bewo) by dietary bioactive compounds and drugs of abuse. J Biochem. 2008;144(2):177–86. doi:10.1093/jb/mvn054
   PubMed Web of Science ®Google Scholar
• Correia-Branco A, Azevedo CF, Araújo JR, Guimarães JT, Faria A, Keating E, Martel F. Xanthohumol impairs glucose uptake by a human first-trimester extravillous trophoblast cell line (htr-8/svneo cells) and impacts the process of placentation. Mol Hum Reprod. 2015;21(10):803–15. doi:10.1093/molehr/gav043
   PubMed Web of Science ®Google Scholar
• Andrade N, Araujo JR, Correia-Branco A, Carletti JV, Martel F. Effect of dietary polyphenols on fructose uptake by human intestinal epithelial (caco-2) cells. J Funct Foods. 2017;36:429–39. doi:10.1016/j.jff.2017.07.032
   Web of Science ®Google Scholar
• Faria A, Pestana D, Monteiro R, Oliveira J, Freitas V d, Azevedo I, Calhau C, Mateus N. Influence of anthocyanins and derivative pigments from blueberry (vaccinium myrtillus) extracts on MPP + intestinal uptake: A structure–activity approach. Food Chem. 2008;109(3):587–94. doi:10.1016/j.foodchem.2008.01.009
   Web of Science ®Google Scholar
• Keating E, Lemos C, Azevedo I, Martel F. Characteristics of thiamine uptake by the bewo human trophoblast cell line. J Biochem Mol Biol. 2006;39(4):383–93. doi:10.5483/bmbrep.2006.39.4.383
   PubMedGoogle Scholar
• Lemos C, Peters GJ, Jansen G, Martel F, Calhau C. Modulation of folate uptake in cultured human colon adenocarcinoma caco-2 cells by dietary compounds. Eur J Nutr. 2007;46(6):329–36. doi:10.1007/s00394-007-0670-y
   PubMed Web of Science ®Google Scholar
• Keating E, Lemos C, Goncalves P, Martel F. Acute and chronic effects of some dietary bioactive compounds on folic acid uptake and on the expression of folic acid transporters by the human trophoblast cell line bewo. J Nutr Biochem. 2008;19(2):91–100. doi:10.1016/j.jnutbio.2007.01.007
   PubMed Web of Science ®Google Scholar
• Goncalves P, Araujo JR, Pinho MJ, Martel F. In vitro studies on the inhibition of colon cancer by butyrate and polyphenolic compounds. Nutr Cancer. 2011;63(2):282–94. doi:10.1080/01635581.2011.523166
   PubMed Web of Science ®Google Scholar
• Correia-Branco A, Keating E, Martel F. Arachidonic acid reverses xanthohumol-induced insufficiency in a human first-trimester extravillous trophoblast cell line (htr-8/svneo cells). Reprod Sci. 2018;25(9):1394–405. doi:10.1177/1933719117746762
   PubMed Web of Science ®Google Scholar
• Martel F, Guedes M, Keating E. Effect of polyphenols on glucose and lactate transport by breast cancer cells. Breast Cancer Res Treat. 2016;157(1):1–11. doi:10.1007/s10549-016-3794-z
   PubMed Web of Science ®Google Scholar
• Payen VL, Porporato PE, Danhier P, Vazeille T, Blackman M. catechin in a 1:2 complex with lysine inhibits cancer cell migration and metastatic take in mice. Front Pharmacol. 2017;8:869. (+)
   PubMed Web of Science ®Google Scholar
• Silva C, Correia-Branco A, Andrade N, Ferreira AC, Soares ML, Sonveaux P, Stephenne J, Martel F. Selective pro-apoptotic and antimigratory effects of polyphenol complex catechin:Lysine 1:2 in breast, pancreatic and colorectal cancer cell lines. Eur J Pharmacol. 2019;859:172533. doi:10.1016/j.ejphar.2019.172533
   PubMed Web of Science ®Google Scholar
• Bergmeyer HU, Bernt E. 1974. Lactate dehydrogenase. Uv-assay with pyruvate and nadh. In Methods of enzymatic analysis. (Press, A., Ed.), pp p. 574–578. New York: Elsevier.
   Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54. doi:10.1006/abio.1976.9999
   PubMed Web of Science ®Google Scholar
• Karunakaran S, Ramachandran S, Coothankandaswamy V, Elangovan S, Babu E, Periyasamy-Thandavan S, Gurav A, Gnanaprakasam JP, Singh N, Schoenlein PV, et al. Slc6a14 (atb0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer. J Biol Chem. 2011;286(36):31830–8. doi:10.1074/jbc.M111.229518
   PubMed Web of Science ®Google Scholar
• Nalecz KA. Amino acid transporter slc6a14 (atb(0,+)) - a target in combined anti-cancer therapy. Front Cell Dev Biol. 2020;8:594464.
   PubMed Web of Science ®Google Scholar
• Müller A, Chiotellis A, Keller C, Ametamey SM, Schibli R, Mu L, Krämer SD. Imaging tumour atb0,+ transport activity by pet with the cationic amino acid o-2((2-[18f]fluoroethyl)methyl-amino)ethyltyrosine. Mol Imaging Biol. 2014;16(3):412–20. doi:10.1007/s11307-013-0711-2
   PubMed Web of Science ®Google Scholar
• Karunakaran S, Umapathy NS, Thangaraju M, Hatanaka T, Itagaki S, Munn DH, Prasad PD, Ganapathy V. Interaction of tryptophan derivatives with slc6a14 (atb0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy. Biochem J. 2008;414(3):343–55. doi:10.1042/BJ20080622
   PubMed Web of Science ®Google Scholar
• Chiu M, Sabino C, Taurino G, Bianchi MG, Andreoli R, Giuliani N, Bussolati O. GPNA inhibits the sodium-independent transport system l for neutral amino acids. Amino Acids. 2017;49(8):1365–72. doi:10.1007/s00726-017-2436-z
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao T, Li Z, Wang L, Yuan S, Sun L. The role of asct2 in cancer: A review. Eur J Pharmacol. 2018;837:81–7. doi:10.1016/j.ejphar.2018.07.007
   PubMed Web of Science ®Google Scholar
• Cha YJ, Kim ES, Koo JS. Amino acid transporters and glutamine metabolism in breast cancer. IJMS. 2018;19(3):907–24. doi:10.3390/ijms19030907
   Web of Science ®Google Scholar
• Broer A, Rahimi F, Broer S. Deletion of amino acid transporter asct2 (slc1a5) reveals an essential role for transporters snat1 (slc38a1) and snat2 (slc38a2) to sustain glutaminolysis in cancer cells. J Biol Chem. 2016;291(25):13194–205. doi:10.1074/jbc.M115.700534
   PubMed Web of Science ®Google Scholar
• Wang K, Cao F, Fang W, Hu Y, Chen Y, Ding H, Yu G. Activation of snat1/slc38a1 in human breast cancer: Correlation with p-akt overexpression. BMC Cancer. 2013;13:343. doi:10.1186/1471-2407-13-343
   PubMed Web of Science ®Google Scholar
• Prat A, Cruz C, Hoadley KA, Díez O, Perou CM, Balmaña J. Molecular features of the basal-like breast cancer subtype based on brca1 mutation status. Breast Cancer Res Treat. 2014;147(1):185–91. doi:10.1007/s10549-014-3056-x
   PubMed Web of Science ®Google Scholar
• van Geldermalsen M, Wang Q, Nagarajah R, Marshall AD, Thoeng A, Gao D, Ritchie W, Feng Y, Bailey CG, Deng N, et al. Asct2/slc1a5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene. 2016;35(24):3201–8. doi:10.1038/onc.2015.381
   PubMed Web of Science ®Google Scholar
• Kim SY, Lee IS, Moon A. 2-hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells. Chem Biol Interact. 2013;203(3):565–72. doi:10.1016/j.cbi.2013.03.012
   PubMed Web of Science ®Google Scholar
• Bartmańska A, Tronina T, Popłoński J, Milczarek M, Filip-Psurska B, Wietrzyk J. Highly cancer selective antiproliferative activity of natural prenylated flavonoids. Molecules. 2018;23(11):2922–36. doi:10.3390/molecules23112922
   PubMed Web of Science ®Google Scholar
• Tronina T, Bartmańska A, Filip-Psurska B, Wietrzyk J, Popłoński J, Huszcza E. Fungal metabolites of xanthohumol with potent antiproliferative activity on human cancer cell lines in vitro. Bioorg Med Chem. 2013;21(7):2001–6. doi:10.1016/j.bmc.2013.01.026
   PubMed Web of Science ®Google Scholar
• Sun Z, Zhou C, Liu F, Zhang W, Chen J, Pan Y, Ma Lianqing, Liu Q, Du Y, Yang J, et al. Inhibition of breast cancer cell survival by xanthohumol via modulation of the notch signaling pathway in vivo and in vitro. Oncol Lett. 2018;15(1):908–16. doi:10.3892/ol.2017.7434
   PubMed Web of Science ®Google Scholar
• Yoo YB, Park KS, Kim JB, Kang HJ, Yang JH, Lee EK, Kim HY. Xanthohumol inhibits cellular proliferation in a breast cancer cell line (mda-mb231) through an intrinsic mitochondrial-dependent pathway. Indian J Cancer. 2014;51(4):518–23. doi:10.4103/0019-509X.175328
   PubMed Web of Science ®Google Scholar
• Gazzola RF, Sala R, Bussolati O, Visigalli R, Dall’Asta V, Ganapathy V, Gazzola GC. The adaptive regulation of amino acid transport system a is associated to changes in ata2 expression. FEBS Lett. 2001;490(1-2):11–4. doi:10.1016/S0014-5793(01)02126-3
   PubMed Web of Science ®Google Scholar
• Franchi-Gazzola R, Dall’Asta V, Sala R, Visigalli R, Bevilacqua E, Gaccioli F, Gazzola GC, Bussolati O. The role of the neutral amino acid transporter snat2 in cell volume regulation. Acta Physiol (Oxf). 2006;187(1-2):273–83. doi:10.1111/j.1748-1716.2006.01552.x
   PubMed Web of Science ®Google Scholar
• Morotti M, Zois CE, El-Ansari R, Craze ML, Rakha EA, Fan S-J, Valli A, Haider S, Goberdhan DCI, Green AR, et al. Increased expression of glutamine transporter snat2/slc38a2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer. Br J Cancer. 2021;124(2):494–505. doi:10.1038/s41416-020-01113-y
   PubMed Web of Science ®Google Scholar
• Morotti M, Bridges E, Valli A, Choudhry H, Sheldon H, Wigfield S, Gray N, Zois CE, Grimm F, Jones D, et al. Hypoxia-induced switch in snat2/slc38a2 regulation generates endocrine resistance in breast cancer. Proc Natl Acad Sci U S A. 2019;116(25):12452–61. doi:10.1073/pnas.1818521116
   PubMed Web of Science ®Google Scholar
• Freidman N, Chen I, Wu Q, Briot C, Holst J, Font J, Vandenberg R, Ryan R. Amino acid transporters and exchangers from the slc1a family: Structure, mechanism and roles in physiology and cancer. Neurochem Res. 2020;45(6):1268–86. doi:10.1007/s11064-019-02934-x
   PubMed Web of Science ®Google Scholar
• Marshall AD, van Geldermalsen M, Otte NJ, Lum T, Vellozzi M, Thoeng A, Pang A, Nagarajah R, Zhang B, Wang Q, et al. Asct2 regulates glutamine uptake and cell growth in endometrial carcinoma. Oncogenesis. 2017;6(7):e367–e377. doi:10.1038/oncsis.2017.70
   PubMed Web of Science ®Google Scholar
• Wang L, Liu Y, Zhao T-L, Li Z-Z, He J-Y, Zhang B-J, Du H-Z, Jiang J-W, Yuan S-T, Sun L, et al. Topotecan induces apoptosis via asct2 mediated oxidative stress in gastric cancer. Phytomedicine. 2019;57:117–28. doi:10.1016/j.phymed.2018.12.011
   PubMed Web of Science ®Google Scholar
• Gianni L, Norton L, Wolmark N, Suter TM, Bonadonna G, Hortobagyi GN. Role of anthracyclines in the treatment of early breast cancer. J Clin Oncol. 2009;27(28):4798–808. doi:10.1200/JCO.2008.21.4791
   PubMed Web of Science ®Google Scholar
• Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, Moreira PI. Doxorubicin: The good, the bad and the ugly effect. Curr Med Chem. 2009;16(25):3267–85. doi:10.2174/092986709788803312
   PubMed Web of Science ®Google Scholar
• Liu M, Yin H, Qian X, Dong J, Qian Z, Miao J. Xanthohumol, a prenylated chalcone from hops, inhibits the viability and stemness of doxorubicin-resistant mcf-7/adr cells. Molecules. 2016;22(1):36–48. doi:10.3390/molecules22010036
   PubMed Web of Science ®Google Scholar
• Monteiro R, Calhau C, Martel F, Faria A, Mateus N, Azevedo I. Modulation of MPP + uptake by tea and some of its components in caco-2 cells. Naunyn Schmiedebergs Arch Pharmacol. 2005;372(2):147–52. doi:10.1007/s00210-005-0012-7
   PubMed Web of Science ®Google Scholar